Clinical Trials List
Protocol NumberWP41377
Completed
2020-05-01 - 2022-12-25
Phase I
Terminated2
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
100 participants
